Introduction
============

Breast cancer is still the leading cause of death in women worldwide ([@b1-or-28-02-0429]). Although the detection rate of breast carcinoma has improved, many female patients die from metastatic relapse. Mammography is the best available method for detection of breast cancer after the age of 50; although, the detection rate of mammography is not as good in younger women due to their high density breast tissue ([@b2-or-28-02-0429]). Early detection is beneficial in the fight against breast cancer. Currently, there are no clinical biomarkers available for early detection of breast cancer. Markers such as CA15.3 and CEA are useful, in combination with imaging and physical examination, for monitoring ongoing treatment in breast cancer patients with metastatic disease; although, they both lack the clinical specificity and sensitivity to be used routinely as a clinical diagnostic tool ([@b3-or-28-02-0429]).

The development of high-throughput techniques in Proteomics expanded the search for new biomarkers and enabled the identification of proteins that may have a crucial role in emerging and progressing breast cancer. Proteome analysis of body fluids, such as sera, tear film, or urine, is a hot topic in Proteomics ([@b4-or-28-02-0429]--[@b6-or-28-02-0429]). Li *et al* found three differently regulated proteins in the sera of breast cancer patients and healthy subjects using surface-enhanced laser desorption/ionization time-of-flight based protein profiling in 2002 and Mathelin *et al* tried to validate these putative biomarkers, determining only two of them could be used for the discrimination of cancer patients ([@b7-or-28-02-0429],[@b8-or-28-02-0429]) (reviewed in refs. [@b9-or-28-02-0429],[@b10-or-28-02-0429]). Some studies examined the nipple aspirate fluid of breast cancer patients and healthy patients ([@b11-or-28-02-0429]). In 2005, Pawlik *et al* showed 17 distinctly regulated peptides; whereas, Li *et al* found different protein distribution patterns in the nipple aspirate fluid and ductal lavage with the use of SELDI-TOF mass spectrometry ([@b12-or-28-02-0429],[@b13-or-28-02-0429]). Since then, many other protein profiling studies were published that used matrix-assisted laser desorption/ionization time-of-flight/time-of-flight mass spectrometry with differently regulated proteins ([@b14-or-28-02-0429]--[@b16-or-28-02-0429]). The advantage of the MALDI-TOF-TOF MS is the subsequent identification of the proteins of interest. In a previous study, we reported data from MALDI-TOF-TOF-based profiling of the sera that could distinguish breast cancer patients from age-matched healthy controls, and we could classify cancer patients with a high sensitivity of 89% ([@b17-or-28-02-0429]).

Another proteomics-based approach for the exploration of cancer-derived differences is the highly-precise microarray platform. This approach can serve, instead of the common ELISA test, as a validation tool for the biomarkers identified from prior MALDI-TOF-TOF-based explorations of the proteome. Here, the antibodies are fixed on a highly-optimized surface. In this manner, several protein levels can be measured simultaneously due to the small required volume (nl) of the reagents. After fixation of the antibodies, the surfaces can be incubated with body fluids containing the appropriate proteins. This high-throughput technique is also very common for the profiling of carcinoma tissue or body fluids of diseased patients due to its miniaturized size, accuracy, and automated handling ([@b18-or-28-02-0429]--[@b20-or-28-02-0429]) (reviewed in ref. [@b21-or-28-02-0429]). Several comparative studies of breast cancer and healthy sera have been published. Our study group reported the regulation of several proteins were significantly different in the sera of breast cancer patients ([@b22-or-28-02-0429]). The discovery of different protein patterns in diseased cohorts and control samples and subsequent identification of these biomarkers is a promising method of obtaining knowledge about the effects of several diseases ([@b6-or-28-02-0429],[@b23-or-28-02-0429],[@b24-or-28-02-0429]). A well-developed and clinically proven biomarker signature could lead to early detection of cancer, which can have great benefits for patients.

Most proteomic studies of breast carcinoma published so far concentrate on profiling the tissue or body fluids near the emergence spot. Little is known about the proteome changes of distant body fluids. Some research groups examined the protein profiles of alternative body fluids such as urine or saliva and several differently regulated proteins were reported (reviewed in refs. [@b25-or-28-02-0429],[@b26-or-28-02-0429]). Previously, we showed different protein distributions in the tear fluid of breast cancer patients and healthy controls in a SELDI-TOF-based profiling study ([@b17-or-28-02-0429],[@b27-or-28-02-0429]). Another comparative MALDI-TOF-TOF-driven analysis of healthy dog's tear fluid and dogs diagnosed with cancer has been published ([@b28-or-28-02-0429]). To our knowledge, no other comparative tear fluid proteomic studies for breast cancer have been reported. Tear fluid has unique properties as retrieval is minimally invasive and it does not contain as many highly-abundant proteins as serum.

Herein, we report a MALDI-TOF-TOF-driven semi-quantitative comparison of tear protein levels in cancer (CA) and control (CTRL) using a *de novo* approach in pooled samples. Using a signature of biomarkers significantly decreased or increased in groups of CA and CTRL could help to discriminate diseased women from the healthy population with high specificity and sensitivity and possibly lead to the establishment of a molecular diagnostic tool for breast cancer.

Materials and methods
=====================

Comparison of tear protein levels in pooled samples from CA and CTRL
--------------------------------------------------------------------

This *de novo* study included 50 female subjects, 25 patients were diagnosed with primary invasive breast carcinoma and treated at the University Medical Center Mainz. At the time of diagnosis, none of the patients had developed distant metastases. Patients' characteristics are summarized in [Table I](#tI-or-28-02-0429){ref-type="table"}. The healthy control subjects were 25 age-matched women without any known malignancies who were treated at the University of Mainz medical center. All study members gave their informed consent for voluntary participation in this study. The protocols were approved by the institutional ethics committee in accordance with the ethical standard of Declaration of Helsinki (1964).

Sample retrieval
----------------

Tear fluid was obtained from all participants using a Schirmer Strip. After the samples were drawn, the strips were frozen immediately at −80°C to prevent protein degradation. Tear proteins were prepared under strict and identical conditions for all patients. Prior to the experiments, the wet strip part was cut into small pieces and incubated with n-Dodecyl-β-D-maltoside overnight at 4°C with constant shaking. The next day, the eluates were briefly centrifuged and transferred into fresh tubes. All samples were stored prior to analysis at −20°C.

Sample processing
-----------------

For the comparison of protein levels in CTRL and CA, each of the 25 tear eluates were pooled together accordingly to the group and precipitated with three times the volume of acetone overnight at −80°C. The next day, tear proteins were centrifuged at 14000 × g and 4°C to prevent protein degradation. The supernatant was discarded and the proteins were resuspended in PBS. Protein concentrations were measured with the BCA Protein Assay kit (Thermo Scientific, Rockford IL, USA), according to the manufacturer's protocol.

1D SDS-PAGE and sample purification
-----------------------------------

Pooled tear proteins (60 μg) from CTRL and CA were separated by molecular weight using 1D SDS-PAGE (gels, buffers, and equipment all purchased from Invitrogen, Darmstadt, Germany). After gel electrophoresis, the lanes were stained overnight and then rinsed with double-distilled water. In the next step, the lanes were subdivided into 32 bands and the proteins were digested with endopeptidase trypsin according to the modified digestion protocol from Shevchenko *et al*([@b29-or-28-02-0429]). For the purification and desalting of peptides, automated sample handling was preferred to reduce the fluctuations from measured proteins due to manual processing of the samples. The purification and the stepwise elution of the peptides with 10--50% acetonitrile were performed using C18 ZipTips (Millipore, Billerica, USA) on the Freedom EVO^®^, purification station (Tecan Group Ltd., Männedorf, Switzerland). The eluted proteins (3 μl) were directly spotted on the MALDI TOF/TOF polished steel target and coated with 3 μl crystallization matrix (20 mg cinnamic acid/50% acetonitrile/2% trifluoroacetic acid). The matrix included 0.5 μl of a Reserpine solution (1 mg/ml) dissolved in methanol for signal normalization. All samples were measured head-to-head to avoid protein degradation and measurement fluctuations in the MALDI-TOF/TOF mass spectrometer (UltraflexII, Bruker Daltonik GmbH, Bremen, Germany). The peak detection was performed with internal calibration mix (Peptide calibration standard II, Bruker Daltonik GmbH).

Data processing
---------------

After MALDI-TOF/TOF measurements, the spectra were exported into Proteomics Pipeline Mainz (P^2^M) software, developed in-house, and normalized according to the Reserpine peaks. Proteins were identified using the MASCOT protein search tool ([@b30-or-28-02-0429]). The Swissprot database was chosen for the identification of proteins ([@b31-or-28-02-0429]). The following general parameters were used: carbamidomethyl as a global modification and oxidation (M) as a variable modification with an MS tolerance of 100 ppm and MS/MS tolerance of 0.8. Only one miscleaved site was allowed and the MudPIT scoring system was used. For further analysis of the protein regulation levels, the intensities of the peptides for each protein were summed and the ratio of the intensity between both groups was calculated for each protein. Significant differences in protein expression levels were defined as at least two times higher or lower expression than the other group. STRING and Cytoscape software were used for the analysis of protein-protein interactions ([@b32-or-28-02-0429],[@b33-or-28-02-0429]).

Results
=======

In this study we conducted an explorative and comparative analysis of the tear proteome of breast carcinoma patients and age-matched healthy controls. We tried to minimize protein degradation and fluctuations of protein measurements to achieve a precise comparison of protein levels. One person performed the experimental steps for the preparation of tear samples for 1D SDS-PAGE until the transfer of digested fractions onto the sample plate for the robotic purification station. The peptide purification was performed automatically to avoid fluctuations due to the manual handling of samples. Likewise, the experimental steps from the precipitation of the tear eluates were also performed by the same person.

Semiquantitative comparison of protein levels in CA and CTRL
------------------------------------------------------------

After destaining, a grid made of 32 bands was put under the gel for a more accurate comparison of the proteins. Each of the 32 bands from CTRL and CA were cut out and digested with trypsin overnight. [Fig. 1](#f1-or-28-02-0429){ref-type="fig"} shows the samples after 1D SDS-PAGE separation and staining with Coomassie dye (Colloidal Blue Staining kit, Invitrogen). After digestion and automated fractionation, the peptides were measured in a MALDI-TOF-TOF mass spectrometer. Representative fractions from both groups are shown in [Fig. 2](#f2-or-28-02-0429){ref-type="fig"}. All spectra were normalized using Protein Pipeline Mainz software, which was developed in-house, and the appropriate tear proteins were identified with the MASCOT search tool.

Protein identification
----------------------

After extensive comparison of the spectra obtained using the annotated proteins in the SWISSPROT Homo sapiens database under the given conditions and MOWSE score, we were able to identify over 150 proteins in the CTRL and CA. The complete merged list of identified proteins is summarized in [Table II](#tII-or-28-02-0429){ref-type="table"}. To obtain an overview on the relevance and role of the identified proteins, we clustered the proteins in accordance to their molecular functions using the software Cytoscape 2.7.0, as shown in [Fig. 3](#f3-or-28-02-0429){ref-type="fig"}. The Cytoscape software often shows several overlapping molecular functions and distributions into several biological processes; therefore, we created an overview of one mapping possibility for a large number of the identified tear proteins.

Using the in-house-developed algorithm, we compared the protein levels in both groups. More than 20 proteins were distinctly upregulated or downregulated in the CTRL and CA groups and were involved in many biological processes such as metabolism (ALDH3A or TPI) or immune response (e.g., C1Q1 or S100A8). [Table III](#tIII-or-28-02-0429){ref-type="table"} shows a detailed list of the increased or decreased proteins in the tear fluid of breast cancer patients. Of note, the findings include inflammation proteins or complement factors for pathologic processes such as cancer that have already been described ([@b34-or-28-02-0429]--[@b36-or-28-02-0429]). Moreover, several proteins show at least four-fold higher (Extracellular sulfatase Sulf-1, Cystatin SA, cst2; 5-AMP-activated protein kinase subunit gamma-3, prkag3; Triosephosphate isomerase, tpi1; Microtubule-associated tumor suppressor 1, mtus1; Transferrin receptor protein 1, trfc; and Putative lipocalin 1-like protein 1, lcn1l1) or lower levels (DNA damage-binding protein 1, ddb1; Protein S100-A9, s100a9; and GTP-binding protein Di-Ras2, diras2) in CA. An overview of the proteins differently regulated in the CA group was constructed according to their regulation using the STRING tool and is shown in [Fig. 4](#f4-or-28-02-0429){ref-type="fig"}([@b32-or-28-02-0429]).

Discussion
==========

Data from high-throughput proteomic technologies, such as SELDI-TOF MS, MALDI-TOF-TOF MS, and microarray platforms, have recently increased. These techniques allow simultaneous protein profiling and subsequent identification of proteins and their subunits ([@b5-or-28-02-0429],[@b37-or-28-02-0429],[@b38-or-28-02-0429]). A huge number of proteome studies have been published for proteome comparison of cancer patients and controls. Likewise, different proteomic studies reported significant differences in protein levels in the body fluids of breast cancer patients and healthy subjects ([@b38-or-28-02-0429],[@b39-or-28-02-0429]). In our study, we concentrated on the tear proteome for several reasons. First, the sample retrieval is minimally invasive for the participants and tear fluid is easy to obtain with a simple Schirmer test. Second, the tear proteome contains no high-abundant proteins, such as albumin and immunoglobulins that are found in serum; therefore, it is not necessary to perform additional depletion steps that may cause distortion of potentially important proteins. In addition, we find it very intriguing to explore the tear proteome for potential biomarkers of breast cancer as it is an uncommon approach.

Some of the differently regulated proteins in our *de novo* pooled experiment have been reported to be altered in the tear fluid of patients with ophthalmic disease. Zhou *et al* reported S100A8 and S100A9 are increased in patients with dry eyes and Grus *et al* reported an increase in protein S100A8 ([@b34-or-28-02-0429],[@b40-or-28-02-0429]). Both proteins belong to the family of S100 calcium-binding proteins, whose members seem to be involved in pro-inflammatory pathways as previously reported by Nacken *et al*([@b35-or-28-02-0429]). Some of the proteins may be of high interest, e.g., Mitochondrial tumor suppressor 1, MTUS1 and DNA damage binding protein, DDB1. MTUS1 regulates the cell cycle by acting as a tumor suppressor and DDB1 is involved in nucleotide excision repair. In addition, many of the differently regulated proteins are involved in metabolic processes, e.g., TPI or MDH1 in glycolysis and the citric acid cycle, which are both increased in the tear fluid of cancer patients. However, higher levels of autoantibodies against TPI1 have been reported in the sera of breast cancer patients ([@b36-or-28-02-0429]). In our previous studies, we found several alterations in protein expression in the sera and tear fluid of breast cancer patients ([@b22-or-28-02-0429],[@b41-or-28-02-0429]). Further analysis of the SELDI-TOF-based tear proteome profiling identified the protein S100A4 to be increased in the tears of breast cancer patients (data not shown). This result was confirmed in this study. The protein S100A4 was also previously found to be upregulated in patients with dry eye syndrome ([@b40-or-28-02-0429]). Noteworthy, we observed several alterations in the level of proteins involved in immune response, such as complement factor C1Q1 or fragments of immunoglobulins ([Table II](#tII-or-28-02-0429){ref-type="table"}). Also, several complement factors have been reported to be differentially regulated in the sera of cancer patients ([@b42-or-28-02-0429],[@b43-or-28-02-0429]). Although, some of the results were controversial and may have resulted from different storage and handling conditions ([@b44-or-28-02-0429]). Thus, members of the complement system may have additional roles. Markiewski *et al* reported tumor growth was promoted by C5a in their experiments with a cervical cancer mouse model ([@b45-or-28-02-0429],[@b46-or-28-02-0429]).

To our knowledge, little is known about protein expression in the tear fluid of breast cancer patients. Only a very small number of tear proteome studies concerning proteome changes during breast cancer or cancer in general have been published. Further subsequent analyses and validation of our results in a tear protein study with an independent population and a higher number of participants will follow that also includes individual profiling. The findings from this study are intriguing as they may deepen the understanding of the impact of cancer and several cancer-driven pathways. Our study demonstrates that different biological processes are altered not only in prominent and broadly investigated body fluids such as serum and plasma, but also in discrete fluids such as tears that are located far away from the cancer site. As we already mentioned, several proteins have been reported to be modified in various types of body fluids, such as nipple aspirate fluid or urine. Our pilot study adds to these findings and shows again the complexity and multiple impacts of breast cancer while emerging and developing in the host, affecting biological processes and signal cascades. Moreover, we propose that a biomarker panel consisting of different proteins could accurately discriminate cancer patients from healthy controls. Therefore, it is important to examine the protein levels in an independent study population using individual protein profiling to validate our results. Further *de novo* approaches and validation of our results could lead to a better understanding of the pathological mechanism of breast cancer.

This study was partially supported by funding from the Mainz research program (MAIFOR NR. 122), University Medical Centre Mainz. Some of the data were developed within the doctoral thesis of Julia Pieter.

![The stained tear samples from CTRL and CA. As an example, the composed grid is shown on the CTRL lane. The lane M shows the protein standard (SeeBlue^®^ Plus2 Pre-Stained Standard Invitrogen, Darmstadt, Germany).](OR-28-02-0429-g00){#f1-or-28-02-0429}

![Mass spectra of the digested and purified peptides from the CTRL and CA groups. The molecular weight of the digested peptides is shown on the x-axis; while, the y-axis represents the intensity of the signals obtained. The spectra show the peptides derived from the first gel fraction in both groups. Spectra 1 and 2 show the peptides eluted with 10% acetonitrile (ACN). Spectra 3 and 4 demonstrate the peptides after elution with 15% ACN. Spectra 5 and 6 represent peptides from the elution step with 30% ACN. All spectra show the reproducible high intensity of signals. The mass spectra show appropriate differences in the peptide patterns according to the CTRL and CA pools.](OR-28-02-0429-g01){#f2-or-28-02-0429}

![Network of identified proteins in the tear fluid of CA and CTRL. Using the software Cytoscape 2.7.0, we constructed a network of the merged proteins identified in both groups. In this overview, the proteins are clustered according to the molecular functions. The ontology file GO_Molecular_Function was used. Other criteria were: hypergeometric statistic test, accessing overrepresented categories, and significance level of 0.05. The circled areas summarize the identified proteins and their molecular functions as follows: Yellow circle: histone modification, transferase activity; blue circle: binding of DNA, lipids and proteins, transcription activation; red circle: transmembrane transport activity; and green circle: catalytic activity. The yellow color on the nodes indicates a higher number of the assigned proteins.](OR-28-02-0429-g02){#f3-or-28-02-0429}

![Using the software, STRING, we constructed an overview of the proteins that were at least 2-fold differently regulated in CTRL and CA. The appropriate gene names are abbreviated. The arrows show the increase (red arrow) or decrease (blue arrow) of the proteins in CA. Some of the known interactions of the proteins are shown with connection lines. The thickness of the lines shows how strong the interactions are.](OR-28-02-0429-g03){#f4-or-28-02-0429}

###### 

Characteristics of breast cancer patients.

  -------------------------------------------------------------------------------
  Characteristic                    Breast cancer patients\   Healthy controls\
                                    n=25 (%)                  n=25
  --------------------------------- ------------------------- -------------------
  Mean age (distribution)           58 (39--85)               58 (39--85)

  Tumor size                                                  

   pT1                              16 (64)                   

   pT2                              9 (36)                    

  Nodal status                                                

   Negative                         18 (72)                   

   Positive                         7 (28)                    

  Grading                                                     

   Well differentiated (G1)         6 (24)                    

   Moderately differentiated (G2)   14 (56)                   

   Poor/undifferentiated (G3)       5 (20)                    

  Distant metastases                                          

   M0                               25 (100)                  

   M1                               0 (0)                     
  -------------------------------------------------------------------------------

###### 

Proteins identified from tear proteomes of CA and CTRL.

  Protein       Description                                                                           Organism species (OS)   Gene name (GN)
  ------------- ------------------------------------------------------------------------------------- ----------------------- ----------------
  TRFL_HUMAN    Lactotransferrin                                                                      Homo sapiens            LTF
  LCN1_HUMAN    Lipocalin-1                                                                           Homo sapiens            LCN1
  ALBU_HUMAN    Serum albumin                                                                         Homo sapiens            ALB
  IGKC_HUMAN    Ig κ chain C region                                                                   Homo sapiens            IGKC
  SG2A1_HUMAN   Mammaglobin-B                                                                         Homo sapiens            SCGB2A1
  LYSC_HUMAN    Lysozyme C                                                                            Homo sapiens            LYZ
  PIP_HUMAN     Prolactin-inducible protein                                                           Homo sapiens            PIP
  DMBT1_HUMAN   Deleted in malignant brain tumors 1 protein                                           Homo sapiens            DMBT1
  IGHA1_HUMAN   Ig α-1 chain C region                                                                 Homo sapiens            IGHA1
  IGHA2_HUMAN   Ig α-2 chain C region                                                                 Homo sapiens            IGHA2
  GSTP1_HUMAN   Glutathione S-transferase P                                                           Homo sapiens            GSTP1
  ZA2G_HUMAN    Zinc-α-2-glycoprotein                                                                 Homo sapiens            AZGP1
  ACTB_HUMAN    Actin, cytoplasmic 1                                                                  Homo sapiens            ACTB
  CYTN_HUMAN    Cystatin-SN                                                                           Homo sapiens            CST1
  LC1L1_HUMAN   Putative lipocalin 1-like protein 1                                                   Homo sapiens            LCN1L1
  PROL4_HUMAN   Proline-rich protein 4                                                                Homo sapiens            PRR4
  CYTS_HUMAN    Cystatin-S                                                                            Homo sapiens            CST4
  ACTBL_HUMAN   β-actin-like protein 2                                                                Homo sapiens            ACTBL2
  POTEE_HUMAN   POTE ankyrin domain family member E                                                   Homo sapiens            POTEE
  POTEF_HUMAN   POTE ankyrin domain family member F                                                   Homo sapiens            POTEF
  ACTC_HUMAN    Actin, α cardiac muscle 1                                                             Homo sapiens            ACTC1
  LAC2_HUMAN    Ig λ-2 chain C regions                                                                Homo sapiens            IGLC2
  SG1D1_HUMAN   Secretoglobin family 1D member 1                                                      Homo sapiens            SCGB1D1
  S10A9_HUMAN   Protein S100-A9                                                                       Homo sapiens            S100A9
  K1C9_HUMAN    Keratin, type I cytoskeletal 9                                                        Homo sapiens            KRT9
  TMC8_HUMAN    Transmembrane channel-like protein 8                                                  Homo sapiens            TMC8
  K2C1_HUMAN    Keratin, type II cytoskeletal 1                                                       Homo sapiens            KRT1
  LAC1_HUMAN    Ig λ-1 chain C regions                                                                Homo sapiens            IGLC1
  CYTT_HUMAN    Cystatin-SA                                                                           Homo sapiens            CST2
  PIGR_HUMAN    Polymeric immunoglobulin receptor                                                     Homo sapiens            PIGR
  S10A8_HUMAN   Protein S100-A8                                                                       Homo sapiens            S100A8
  APOA1_HUMAN   Apolipoprotein A-I                                                                    Homo sapiens            APOA1
  PROL1_HUMAN   Proline-rich protein 1                                                                Homo sapiens            PROL1
  HSPB1_HUMAN   Heat shock protein β-1                                                                Homo sapiens            HSPB1
  LACRT_HUMAN   Extracellular glycoprotein lacritin                                                   Homo sapiens            LACRT
  ABCA3_HUMAN   ATP-binding cassette sub-family A member 3                                            Homo sapiens            ABCA3
  IGJ_HUMAN     Immunoglobulin J chain                                                                Homo sapiens            IGJ
  ANXA2_HUMAN   Annexin A2                                                                            Homo sapiens            ANXA2
  SSH2_HUMAN    Protein phosphatase Slingshot homolog 2                                               Homo sapiens            SSH2
  KV301_HUMAN   Ig κ chain V-III region B6                                                            Homo sapiens            
  KV307_HUMAN   Ig κ chain V-III region GOL                                                           Homo sapiens            
  TPIS_HUMAN    Triosephosphate isomerase                                                             Homo sapiens            TPI1
  LEG3_HUMAN    Galectin-3                                                                            Homo sapiens            LGALS3
  NGAL_HUMAN    Neutrophil gelatinase-associated lipocalin                                            Homo sapiens            LCN2
  POP1_HUMAN    Ribonucleases P/MRP protein subunit POP1                                              Homo sapiens            POP1
  ZC3H1_HUMAN   Zinc finger C3H1 domain-containing protein                                            Homo sapiens            ZFC3H1
  CLIC1_HUMAN   Chloride intracellular channel protein 1                                              Homo sapiens            CLIC1
  LIME1_HUMAN   Lck-interacting transmembrane adapter 1                                               Homo sapiens            LIME1
  HV307_HUMAN   Ig heavy chain V-III region CAM                                                       Homo sapiens            
  GNL3_HUMAN    Guanine nucleotide-binding protein-like 3                                             Homo sapiens            GNL3
  POTEI_HUMAN   POTE ankyrin domain family member I                                                   Homo sapiens            POTEI
  ENOA_HUMAN    α-enolase                                                                             Homo sapiens            ENO1
  PRDX1_HUMAN   Peroxiredoxin-1                                                                       Homo sapiens            PRDX1
  MECP2_HUMAN   Methyl-CpG-binding protein 2                                                          Homo sapiens            MECP2
  K2C78_HUMAN   Keratin, type II cytoskeletal 78                                                      Homo sapiens            KRT78
  ZG16B_HUMAN   Zymogen granule protein 16 homolog B                                                  Homo sapiens            ZG16B
  YM012_HUMAN   Uncharacterized protein DKFZp434B061                                                  Homo sapiens            
  YV021_HUMAN   Uncharacterized protein LOC284861                                                     Homo sapiens            
  ILEU_HUMAN    Leukocyte elastase inhibitor                                                          Homo sapiens            SERPINB1
  ANXA1_HUMAN   Annexin A1                                                                            Homo sapiens            ANXA1
  POTEJ_HUMAN   POTE ankyrin domain family member J                                                   Homo sapiens            POTEJ
  PLSL_HUMAN    Plastin-2                                                                             Homo sapiens            LCP1
  NCOA5_HUMAN   Nuclear receptor coactivator 5, protein existence (PE), 1; sequence version (SV), 2   Homo sapiens            NCOA5
  B2MG_HUMAN    β-2-microglobulin                                                                     Homo sapiens            B2M
  KLH34_HUMAN   Kelch-like protein 34                                                                 Homo sapiens            KLHL34
  ANX13_HUMAN   Annexin A13                                                                           Homo sapiens            ANXA13
  MDHC_HUMAN    Malate dehydrogenase, cytoplasmic                                                     Homo sapiens            MDH1
  AIFM2_HUMAN   Apoptosis-inducing factor 2                                                           Homo sapiens            AIFM2
  STAG3_HUMAN   Cohesin subunit SA-3                                                                  Homo sapiens            STAG3
  SMCA4_HUMAN   Transcription activator BRG1                                                          Homo sapiens            SMARCA4
  DDB1_HUMAN    DNA damage-binding protein 1                                                          Homo sapiens            DDB1
  RM18_HUMAN    39S ribosomal protein L18, mitochondrial                                              Homo sapiens            MRPL18
  KRIT1_HUMAN   Krev interaction trapped protein 1                                                    Homo sapiens            KRIT1
  PERT_HUMAN    Thyroid peroxidase                                                                    Homo sapiens            TPO
  HPT_HUMAN     Haptoglobin                                                                           Homo sapiens            HP
  F184A_HUMAN   Protein FAM184A                                                                       Homo sapiens            FAM184A
  AAKG2_HUMAN   5′-AMP-activated protein kinase subunit γ-2                                           Homo sapiens            PRKAG2
  AAKG3_HUMAN   5′-AMP-activated protein kinase subunit γ-3                                           Homo sapiens            PRKAG3
  EIF2A_HUMAN   Eukaryotic translation initiation factor 2A                                           Homo sapiens            EIF2A
  RGPA2_HUMAN   Ral GTPase-activating protein subunit α-2                                             Homo sapiens            RALGAPA2
  TUT4_HUMAN    Terminal uridylyltransferase 4                                                        Homo sapiens            ZCCHC11
  ATP4A_HUMAN   Potassium-transporting ATPase α chain 1                                               Homo sapiens            ATP4A
  YJ017_HUMAN   Putative uncharacterized protein LOC439951                                            Homo sapiens            
  AINX_HUMAN    α-internexin                                                                          Homo sapiens            INA
  TTBK2_HUMAN   Tau-tubulin kinase 2                                                                  Homo sapiens            TTBK2
  SPTN2_HUMAN   Spectrin β chain, brain 2                                                             Homo sapiens            SPTBN2
  MDGA1_HUMAN   MAM domain-containing glycosylphosphatidylinositol anchor protein 1                   Homo sapiens            MDGA1
  FREM3_HUMAN   FRAS1-related extracellular matrix protein 3                                          Homo sapiens            FREM3
  PDE4C_HUMAN   cAMP-specific 3′,5′-cyclic phosphodiesterase 4C                                       Homo sapiens            PDE4C
  SULF1_HUMAN   Extracellular sulfatase Sulf-1                                                        Homo sapiens            SULF1
  LRC4C_HUMAN   Leucine-rich repeat-containing protein 4C                                             Homo sapiens            LRRC4C
  S10A4_HUMAN   Protein S100-A4                                                                       Homo sapiens            S100A4
  LRFN6_HUMAN   Leucine-rich repeat and fibronectin type-III domain-containing protein 6              Homo sapiens            ELFN2
  IGHG3_HUMAN   Ig γ-3 chain C region                                                                 Homo sapiens            IGHG3
  IGHG2_HUMAN   Ig γ-2 chain C region                                                                 Homo sapiens            IGHG2
  ELOA1_HUMAN   Transcription elongation factor B polypeptide 3                                       Homo sapiens            TCEB3
  DLG3_HUMAN    Disks large homolog 3                                                                 Homo sapiens            DLG3
  PDZD7_HUMAN   PDZ domain-containing protein 7                                                       Homo sapiens            PDZD7
  HV315_HUMAN   Ig heavy chain V-III region WAS                                                       Homo sapiens            
  HV304_HUMAN   Ig heavy chain V-III region TIL                                                       Homo sapiens            
  WBS23_HUMAN   Williams-Beuren syndrome chromosomal region 23 protein                                Homo sapiens            WBSCR23
  PKHH3_HUMAN   Pleckstrin homology domain-containing family H member 3                               Homo sapiens            PLEKHH3
  DMXL2_HUMAN   DmX-like protein 2                                                                    Homo sapiens            DMXL2
  CBR3_HUMAN    Carbonyl reductase \[NADPH\] 3                                                        Homo sapiens            CBR3
  CE164_HUMAN   Centrosomal protein of 164 kDa                                                        Homo sapiens            CEP164
  USPL1_HUMAN   Ubiquitin-specific peptidase-like protein 1                                           Homo sapiens            USPL1
  TRFE_HUMAN    Serotransferrin                                                                       Homo sapiens            TF
  MPPA_HUMAN    Mitochondrial-processing peptidase subunit α                                          Homo sapiens            PMPCA
  CABP1_HUMAN   Calcium-binding protein 1                                                             Homo sapiens            CABP1
  TFR1_HUMAN    Transferrin receptor protein 1                                                        Homo sapiens            TFRC
  ZN446_HUMAN   Zinc finger protein 446                                                               Homo sapiens            ZNF446
  MTDC_HUMAN    Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial    Homo sapiens            MTHFD2
  CT151_HUMAN   Uncharacterized protein C20orf151                                                     Homo sapiens            C20orf151
  LIPB2_HUMAN   Liprin-β-2                                                                            Homo sapiens            PPFIBP2
  ZSWM5_HUMAN   Zinc finger SWIM domain-containing protein 5                                          Homo sapiens            ZSWIM5
  WDR60_HUMAN   WD repeat-containing protein 60                                                       Homo sapiens            WDR60
  C1QC_HUMAN    Complement C1q subcomponent subunit C                                                 Homo sapiens            C1QC
  CNOT1_HUMAN   CCR4-NOT transcription complex subunit 1                                              Homo sapiens            CNOT1
  CDK13_HUMAN   Cyclin-dependent kinase 13                                                            Homo sapiens            CDK13
  GLE1_HUMAN    Nucleoporin GLE1                                                                      Homo sapiens            GLE1
  RFIP4_HUMAN   Rab11 family-interacting protein 4                                                    Homo sapiens            RAB11FIP4
  AL3A1_HUMAN   Aldehyde dehydrogenase, dimeric NADP-preferring                                       Homo sapiens            ALDH3A1
  FRMD7_HUMAN   FERM domain-containing protein 7                                                      Homo sapiens            FRMD7
  SEM4C_HUMAN   Semaphorin-4C                                                                         Homo sapiens            SEMA4C
  PRTG_HUMAN    Protogenin                                                                            Homo sapiens            PRTG
  PTPRR_HUMAN   Receptor-type tyrosine-protein phosphatase R                                          Homo sapiens            PTPRR
  HV305_HUMAN   Ig heavy chain V-III region BRO                                                       Homo sapiens            
  TGS1_HUMAN    Trimethylguanosine synthase                                                           Homo sapiens            TGS1
  LRRK2_HUMAN   Leucine-rich repeat serine/threonine-protein kinase 2                                 Homo sapiens            LRRK2
  BMPR2_HUMAN   Bone morphogenetic protein receptor type-2                                            Homo sapiens            BMPR2
  F178A_HUMAN   Protein FAM178A                                                                       Homo sapiens            FAM178A
  MOV10_HUMAN   Putative helicase MOV-10                                                              Homo sapiens            MOV10
  K0556_HUMAN   Uncharacterized protein KIAA0556                                                      Homo sapiens            KIAA0556
  KAT2A_HUMAN   Histone acetyltransferase KAT2A                                                       Homo sapiens            KAT2A
  EAP1_HUMAN    Enhanced at puberty protein 1                                                         Homo sapiens            EAP1
  CA175_HUMAN   Uncharacterized protein C1orf175                                                      Homo sapiens            C1orf175
  ENOG_HUMAN    γ-enolase                                                                             Homo sapiens            ENO2
  ENOB_HUMAN    β-enolase                                                                             Homo sapiens            ENO3
  LOX5_HUMAN    Arachidonate 5-lipoxygenase                                                           Homo sapiens            ALOX5
  MTMR4_HUMAN   Myotubularin-related protein 4                                                        Homo sapiens            MTMR4
  YQ050_HUMAN   Putative uncharacterized protein FLJ45831                                             Homo sapiens            
  TRI75_HUMAN   Tripartite motif-containing protein 75                                                Homo sapiens            TRIM75
  LRIG3_HUMAN   Leucine-rich repeats and immunoglobulin-like domains protein 3                        Homo sapiens            LRIG3
  DSCL1_HUMAN   Down syndrome cell adhesion molecule-like protein 1                                   Homo sapiens            DSCAML1
  CD20_HUMAN    B-lymphocyte antigen CD20                                                             Homo sapiens            MS4A1
  IGHG4_HUMAN   Ig γ-4 chain C region                                                                 Homo sapiens            IGHG4
  MIDA_HUMAN    Protein midA homolog, mitochondrial                                                   Homo sapiens            C2orf56
  SI1L3_HUMAN   Signal-induced proliferation-associated 1-like protein 3                              Homo sapiens            SIPA1L3
  TLE2_HUMAN    Transducin-like enhancer protein 2                                                    Homo sapiens            TLE2
  KLH17_HUMAN   Kelch-like protein 17                                                                 Homo sapiens            KLHL17
  CO7A1_HUMAN   Collagen α-1(VII) chain                                                               Homo sapiens            COL7A1
  MRGRD_HUMAN   Mas-related G-protein coupled receptor member D                                       Homo sapiens            MRGPRD
  MCF2L_HUMAN   Guanine nucleotide exchange factor DBS                                                Homo sapiens            MCF2L
  MTUS1_HUMAN   Microtubule-associated tumor suppressor 1                                             Homo sapiens            MTUS1

###### 

Proteins increased or decreased at least 2-fold in CA.

  A, Increased proteins in CA with fold increase                    
  ------------------------------------------------- --------------- -----------------------------
  Extracellular sulfatase Sulf-1                    44              1
  Cystatin-SA                                       9               2
  5-AMP-activated protein kinase subunit γ-3        6               1
  Triosephosphate isomerase                         5.5             5
  Microtubule-associated tumor suppressor 1         4.7             13
  Transferrin receptor protein 1                    4.5             6
  Keratin, type I cytoskeletal 9                    4.4             17
  Putative lipocalin 1-like protein 1               4.1             1
  Malate dehydrogenase, cytoplasmic                 4               5
  Ig α-2 chain C region                             3.2             2
  Ig heavy chain V-III region BRO                   3.2             6
  Protein S100-A4                                   3.2             1
  Keratin, type II cytoskeletal 1                   3.1             36
  Pericentrin                                       2.8             49
  Ig heavy chain V-III region WEA                   2.7             2
  Complement C1q subcomponent subunit C             2.6             1
                                                                    
  B, Decreased proteins in CA with fold increase                    
                                                                    
  Protein ID                                        Fold decrease   Number of compared peptides
                                                                    
  Aldehyde dehydrogenase, dimeric NADP-preferring   2.1             6
  Immunoglobulin J chain                            2.4             14
  Ig γ-3 chain C region                             2.4             12
  POTE ankyrin domain family member F               2.5             6
  Protein S100-A8                                   2.5             18
  Uncharacterized protein C20orf151                 2.9             9
  Ig γ-4 chain C region                             3               1
  WD repeat-containing protein 60                   3               3
  DNA damage-binding protein 1                      3.3             3
  Protein S100-A9                                   3.3             11
  GTP-binding protein Di-Ras2                       10              1
